TSXV Trading Symbol: FFP
VANCOUVER, BC, Aug. 29, 2024 /CNW/ - The financial results of Consolidated Firstfund Capital Corp. FFP (the "Company" or "Firstfund") for the three months ended June 30, 2024 show a net loss of $59,522 or $0.01 per share (2023 - net loss of $54,599 or $0.01 per share). The Company recorded an unrealized net loss of $70,086 for the three months ended June 30, 2024 (2023 - unrealized net loss of $35,044) on the revaluation of the investments in Vitality Products Inc. VPI measured at fair value through profit or loss. The Company's fee income increased to $94,812 for the three months ended June 30, 2024 (2023 - $85,086).
The Company's condensed consolidated interim financial statements and management's discussion and analysis for the six months ended June 30, 2024 and 2023 are available on SEDAR+ at www.sedarplus.com.
About Firstfund
Consolidated Firstfund Capital Corp. FFP is a venture capital company. The Company is primarily engaged in financial consulting relating to real estate development and venture capital activities in Canada and the United States. The Company is an investment issuer listed on the TSX Venture Exchange. Firstfund has invested its capital in both private companies and publicly traded companies since 1983. The Company continues to investigate other investment opportunities for its portfolio. Firstfund earns fee income for real estate development and property management activities performed on properties owned by other companies and limited partnerships managed by companies under common control.
On behalf of the Board of
CONSOLIDATED FIRSTFUND CAPITAL CORP.
"W. Douglas Grant" (signed)
______________________________
W. Douglas Grant, President & CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Consolidated Firstfund Capital Corp.
View original content: http://www.newswire.ca/en/releases/archive/August2024/29/c4663.html
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
